- Monday, September 14, 2026
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Global Plasma Therapy Market- By Type (Pure PRP, Leucocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin), By Source (Autologous, Allogenic), By Application (Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, Others), By End User (Hospitals & Clinics, Research Institutions), and By Region (North America, Europe, Asia Pacific, South America, and Middle East, & Africa)- Global forecast from 2020-2027.
Global Plasma Therapy Market Overview:
Plasma therapy is a platelet concentrate obtained after centrifugation of whole blood, which contains platelets and growth factors higher than normal levels (at least 4-8 times that of healthy blood). This technology and products used to treat various chronic diseases because they can effectively accelerate wound healing.
Global Plasma Therapy Market Insights
The global Plasma therapy market has the potential to grow with USD 327.52 million with historical CAGR in the forecast period from 2020-2027. Due to the increase in the proportion of orthopedics and sports injuries, the global platelet-rich plasma therapy market proliferates. More and more plastic surgery and chronic or acute diseases in the world are treated with plasma therapy.
In recent years, plasma therapy applications in orthopedic diseases, cardiovascular and neurovascular diseases, general surgery, wound treatment, and plastic surgery are increasing. It is mainly owing to the enhanced tissue repairing ability; the therapeutic effect of platelet-rich plasma is especially noticeable compared with traditional methods.
The driving growth factor of plasma therapy is enrichment technology and shortening of wound healing time. It is coupled with the convenience of the production of such treatments, cost-effectiveness, and the lowest risk of disease transmission. Therefore, such factors are raising the market share for global plasma therapy. Moreover, due to the enhancement of growth factor enrichment technology and shortening of wound healing time, the market share of plasma therapy is expected to show strong growth in the future.
Furthermore, plasma therapy is currently using for treating coronavirus patients. It is useful as it has effects on a variety of infectious diseases. Thus, plasma therapy has now appeared, and it is beneficial and saving many lives of patients dealing with coronavirus infection. Also, plasma therapy does not have any side-effects compared to other drugs. These antibodies help in improving the immune system’s response and assist in clearing the virus from the body.
Additionally, rehabilitation plasma therapy is an essential method for humans to prevent and treat infectious diseases. It primarily used for viral illnesses that have neither vaccines nor specific drugs, including scarlet fever, yellow fever, avian influenza, etc. The 2015 African Ebola virus outbreak at that time, the World Health Organization, had recommended the use of plasma therapy. Therefore, with the explosion of coronavirus plasma therapy is bolstering its market demand.
Growth Driver
Growing geriatric population
The rise in the geriatric population has increased the chance of chronic diseases, a decrease in the immunity of a person lead to a treatment of plasma therapy, patients with low immune systems and are at high risk of having viruses given to them. Therefore, it helps in boosting immunity with no side-effects.
Quick healing and cost-effective method
The plasma therapy is given to the patient when there are no symptoms of viral, to increase the function of the immune system and helps in healing quickly. Moreover, plasma therapy is one of the oldest and effective treatments that are very cost-effective. Thus, it is affordable and helps in saving lots of lives suffering from diseases like coronavirus and other chronic diseases.
By Type Segmental Analysis
Based on the type, the global plasma therapy market categorized into Pure PRP, Leucocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin. The leukocyte-rich fibrin type segment accounted for the largest share in the global plasma therapy market. It is mainly owing to the natural healing proteins that create a potential network of cells that required for better bone regeneration. Moreover, leukocyte-rich fibrin reduces the pain in bones post-treatment and thus, emerging the market share of the global plasma therapy market.
By Source Segmental Analysis
Based on the source, the global plasma therapy market segmented into Autologous, Allogenic. The autologous source segment is estimated to account for the largest share of the plasma therapy market in the forecast period. The prevalence of orthopedic disorders and suitable for the healing of bones and other tissues in the body. Also, the need for the development of new therapies will drive the growth of this autologous source in the global plasma therapy market.
Application Segmental Analysis
Based on the application, the global plasma therapy market classified into Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, Others. The dermatology segment is dominating the market share of the global plasma therapy market. It is mainly owing to the rising demand for cosmetic procedures used for facial rejuvenation processes. Moreover, increasing cases of sports injuries are an increasing number of patients of androgenic alopecia.
By End-User Segmental Analysis
Based on the end-user, the global plasma therapy market bifurcated into Hospitals & Clinics, Research Institutions. The hospitals & clinics segment has dominated the largest share in the global plasma therapy market. It is mainly due to the adoption of advancement in technology, and rising health care facilities are propelling the market demand for comprehensive plasma therapy.
By Region Segmental Analysis
Based on geography, the global plasma therapy market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America region is dominating the market share of the global plasma therapy market. Significant factors contributing to the growth of the plasma therapy market include high incidences of trauma, an increase in healthcare expenditure, and access to medical insurance. On the other hand, stringent regulatory policies and side-effects associated with PRP therapy are restraining the growth of this market.
Competitor Analysis
Companies such as BioLife Plasma Services, Cambryn Biologics LLC, Biotest, CSL Ltd., Grifols International S.A., Kedrion S.p.A. LFB, Bio Products Laboratory Ltd., China Biologic Products, Inc., Octapharma and others are key players in the global plasma therapy market.
Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global plasma therapy service companies
- Research organizations and consulting companies’ plasma therapy
- Regulatory bodies
The objective of the Research
- Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
- Product analysis involves steps such as examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps in assessing potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis defines in-depth scenario of the target market by the process of grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs wants, and cultural characteristics that can be specifically targeted.
Market Modelling
By Type
- Pure PRP
- Leucocyte-rich PRP
- Pure Platelet-rich Fibrin (PRF)
- Leukocyte-rich Fibrin (L-PRF)
By Source
- Autologous
- Allogenic
By Application
- Orthopaedics
- Arthritis
- Chronic Tendinitis
- Bone Repair & Regeneration
- Dermatology
- Androgenic Alopecia
- Plastic Surgery
- Dental
- Cardiac Muscle Injury
- Nerve Injury
- Others
By End-Use
- Hospitals & Clinics
- Research Institutions
By Region
- Europe
- North America
- Asia Pacific
- South America
- Middle East & Africa
Global Plasma Therapy Market
Report Content
- Research Strategic Development
- Market Modelling
- Product Analysis
- Market Trend and Economic Factors Analysis
- Market Segmental Analysis
- Geographical Mapping
- Country Wise Segregation
- Research Methodology
- Identification of Target Market
- Data Acquisition
- Refining of Data/ Data Transformations
- Data Validation through Primary Techniques
- Exploratory Data Analysis
- Graphical Techniques/Analysis
- Quantitative Techniques/Analysis
- Visual Result/Presentation
- Executive Summary
- Market Insights
- Economic Factor Analysis
- Drivers
- Trends
- Opportunities
- Challenges
- Competitors & Product Analysis
- Regulatory Framework
- Company market share analysis, 2019
- Porter’s Five forces analysis
- New Investment Analysis
- PESTEL Analysis
- Economic Factor Analysis
- Global Plasma Therapy Market Overview
- Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Market Share & Forecast, 2016-2027
- By Type
- Pure PRP
- Leucocyte-rich PRP
- Pure Platelet-rich Fibrin (PRF)
- Leukocyte-rich Fibrin (L-PRF)
- By Source
- Autologous
- Allogenic
- By Application
- Orthopaedics
- Arthritis
- Chronic Tendinitis
- Bone Repair & Regeneration
- Dermatology
- Androgenic Alopecia
- Plastic Surgery
- Dental
- Cardiac Muscle Injury
- Nerve Injury
- Others
- Orthopaedics
- By End-Use
- Hospitals & Clinics
- Research Institutions
- By Region
- Europe
- North America
- Asia Pacific
- South America
- Middle East & Africa
- By Type
- Demand
- Market Size & Forecast, 2016-2027
- Europe Plasma Therapy Market Overview
- Europe Plasma Therapy Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Europe Plasma Therapy Market Share & Forecast, 2016-2027
- By Type
- Pure PRP
- Leucocyte-rich PRP
- Pure Platelet-rich Fibrin (PRF)
- Leukocyte-rich Fibrin (L-PRF)
- By Source
- Autologous
- Allogenic
- By Application
- Orthopaedics
- Arthritis
- Chronic Tendinitis
- Bone Repair & Regeneration
- Dermatology
- Androgenic Alopecia
- Plastic Surgery
- Dental
- Cardiac Muscle Injury
- Nerve Injury
- Others
- Orthopaedics
- By End-Use
- Hospitals & Clinics
- Research Institutions
- By Country
- Germany
- UK
- France
- Italy
- Rest of Europe
- Company Market Share (Top 3-5)
- Economic Impact Study on Europe Plasma Therapy Market
- By Type
- Demand
- Europe Plasma Therapy Market Size & Forecast, 2016-2027
- North Plasma Therapy Market Overview
- North America Plasma Therapy Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- North America Plasma Therapy Market Share & Forecast, 2016-2027
- By Type
- Pure PRP
- Leucocyte-rich PRP
- Pure Platelet-rich Fibrin (PRF)
- Leukocyte-rich Fibrin (L-PRF)
- By Source
- Autologous
- Allogenic
- By Application
- Orthopaedics
- Arthritis
- Chronic Tendinitis
- Bone Repair & Regeneration
- Dermatology
- Androgenic Alopecia
- Plastic Surgery
- Dental
- Cardiac Muscle Injury
- Nerve Injury
- Others
- Orthopaedics
- By End-Use
- Hospitals & Clinics
- Research Institutions
- By Country
- US
- Canada
- Mexico
- Company Market Share (Top 3-5)
- Economic Impact Study on North America Plasma Therapy Market
- By Type
- Demand
- North America Plasma Therapy Market Size & Forecast, 2016-2027
- Asia Pacific Plasma Therapy Market Overview
- Asia Pacific Plasma Therapy Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Asia Pacific Plasma Therapy Market Share & Forecast, 2016-2027
- By Type
- Pure PRP
- Leucocyte-rich PRP
- Pure Platelet-rich Fibrin (PRF)
- Leukocyte-rich Fibrin (L-PRF)
- By Source
- Autologous
- Allogenic
- By Application
- Orthopaedics
- Arthritis
- Chronic Tendinitis
- Bone Repair & Regeneration
- Dermatology
- Androgenic Alopecia
- Plastic Surgery
- Dental
- Cardiac Muscle Injury
- Nerve Injury
- Others
- Orthopaedics
- By End-Use
- Hospitals & Clinics
- Research Institutions
- By Country
- China
- India
- Japan
- Australia
- Rest of Asia Pacific
- Company Market Share (Top 3-5)
- Economic Impact Study on Asia Pacific Plasma Therapy Market
- By Type
- Demand
- Asia Pacific Plasma Therapy Market Size & Forecast, 2016-2027
- South America Plasma Therapy Market Overview
- South America Plasma Therapy Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- South America Plasma Therapy Market Share & Forecast, 2016-2027
- By Type
- Pure PRP
- Leucocyte-rich PRP
- Pure Platelet-rich Fibrin (PRF)
- Leukocyte-rich Fibrin (L-PRF)
- By Source
- Autologous
- Allogenic
- By Application
- Orthopaedics
- Arthritis
- Chronic Tendinitis
- Bone Repair & Regeneration
- Dermatology
- Androgenic Alopecia
- Plastic Surgery
- Dental
- Cardiac Muscle Injury
- Nerve Injury
- Others
- Orthopaedics
- By End-Use
- Hospitals & Clinics
- Research Institutions
- By Country
- Brazil
- Argentina
- Rest of South America
- Company Market Share (Top 3-5)
- Economic Impact Study on South America Plasma Therapy Market
- By Type
- Demand
- South America Plasma Therapy Market Size & Forecast, 2016-2027
- Middle East & Africa Plasma Therapy Market Overview
- Middle East & Africa Plasma Therapy Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Middle East & Africa Plasma Therapy Market Share & Forecast, 2016-2027
- By Type
- Pure PRP
- Leucocyte-rich PRP
- Pure Platelet-rich Fibrin (PRF)
- Leukocyte-rich Fibrin (L-PRF)
- By Source
- Autologous
- Allogenic
- By Application
- Orthopaedics
- Arthritis
- Chronic Tendinitis
- Bone Repair & Regeneration
- Dermatology
- Androgenic Alopecia
- Plastic Surgery
- Dental
- Cardiac Muscle Injury
- Nerve Injury
- Others
- Orthopaedics
- By End-Use
- Hospitals & Clinics
- Research Institutions
- By Country
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
- Company Market Share (Top 3-5)
- Economic Impact Study on Middle East & Africa Plasma Therapy Market
- By Type
- Demand
- Middle East & Africa Plasma Therapy Market Size & Forecast, 2016-2027
- Competitor Analysis
- Company Description
- Financial Analysis
- Key Products
- Key Management Personnel
- Contact Address
- SWOT Analysis
- Company Profile
- BioLife Plasma Services
- Cambryn Biologics LLC
- Biotest
- CSL Ltd.
- Grifols International S.A.
- Kedrion S.p.A. LFB
- Bio Products Laboratory Ltd.
- China Biologic Products, Inc.
- Octapharma
- Other players
